STANOZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Stanozide, and what generic alternatives are available?
Stanozide is a drug marketed by Everylife and is included in one NDA.
The generic ingredient in STANOZIDE is isoniazid. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Stanozide
A generic version of STANOZIDE was approved as isoniazid by OMNIVIUM PHARMS on June 26th, 1997.
Summary for STANOZIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 154 |
Patent Applications: | 4,307 |
Formulation / Manufacturing: | see details |
DailyMed Link: | STANOZIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for STANOZIDE
US Patents and Regulatory Information for STANOZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Everylife | STANOZIDE | isoniazid | TABLET;ORAL | 080126-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Everylife | STANOZIDE | isoniazid | TABLET;ORAL | 080126-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |